{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:58:55Z","timestamp":1786993135359,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015965","name":"Yunnan Power Grid Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015308","name":"Xinjiang Uygur Autonomous Region Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015308","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jpba.2026.117444","type":"journal-article","created":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T06:50:06Z","timestamp":1772347806000},"page":"117444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Unraveling the heterogeneity of hyperuricemia using untargeted metabolomics and statistical modeling"],"prefix":"10.1016","volume":"275","author":[{"given":"Juan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongda","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"02","key":"10.1016\/j.jpba.2026.117444_bib1","first-page":"183","article-title":"Guidelines for the diagnosis and treatment of hyperuricemia and gout","volume":"16","author":"Ni","year":"2021","journal-title":"World Chin. Med."},{"issue":"1","key":"10.1016\/j.jpba.2026.117444_bib2","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1038\/s41467-020-16525-w","article-title":"The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion","volume":"11","author":"Hoque","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jpba.2026.117444_bib3","doi-asserted-by":"crossref","first-page":"20148","DOI":"10.1038\/srep20148","article-title":"The effects of URAT1\/SLC22A12 nonfunctional variants, R90H and W258X, on serum uric acid levels and gout\/hyperuricemia progression","volume":"6","author":"Sakiyama","year":"2016","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.jpba.2026.117444_bib4","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1007\/s10067-020-05095-3","article-title":"Neck circumference is an independent risk factor for hyperuricemia within 3 years in women: a longitudinal study","volume":"39","author":"An","year":"2020","journal-title":"Clin. Rheumatol."},{"issue":"8","key":"10.1016\/j.jpba.2026.117444_bib5","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1016\/S2665-9913(24)00117-6","article-title":"Gout Collaborators, Global, regional, and national burden of gout, 1990-2020, and projections to 2050: a systematic analysis of the global burden of disease study 2021","volume":"6","author":"GBD 2021","year":"2024","journal-title":"Lancet Rheumatol."},{"issue":"1","key":"10.1016\/j.jpba.2026.117444_bib6","first-page":"27","article-title":"Gout: state of the art after a decade of developments","volume":"58","author":"Pascart","year":"2019","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.jpba.2026.117444_bib7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41584-018-0004-x","article-title":"An update on the genetics of hyperuricaemia and gout","volume":"14","author":"Major","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"issue":"7","key":"10.1016\/j.jpba.2026.117444_bib8","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3390\/cells11071063","article-title":"Functional characterization of rare variants in OAT1\/SLC22A6 and OAT3\/SLC22A8 urate transporters identified in a gout and hyperuricemia cohort","volume":"11","author":"V\u00e1vra","year":"2022","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.jpba.2026.117444_bib9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/biom11020280","article-title":"Why does hyperuricemia not necessarily induce gout?","volume":"11","author":"Zhang","year":"2021","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.jpba.2026.117444_bib10","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.3390\/jcm9082510","article-title":"Evaluation of the influence of genetic variants of SLC2A9 (GLUT9) and SLC22A12 (URAT1) on the development of hyperuricemia and gout","volume":"9","author":"Pavelcova","year":"2020","journal-title":"J. Clin. Med."},{"issue":"1\u20132","key":"10.1016\/j.jpba.2026.117444_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/A:1013713905833","article-title":"Metabolomics\u2014the link between genotypes and phenotypes","volume":"48","author":"Fiehn","year":"2002","journal-title":"Plant. Mol. Biol."},{"issue":"1\u20132","key":"10.1016\/j.jpba.2026.117444_bib12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000487440","article-title":"Heterogeneity in lung cancer","volume":"85","author":"de Sousa","year":"2018","journal-title":"Pathobiology"},{"issue":"10","key":"10.1016\/j.jpba.2026.117444_bib13","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/14737140.2019.1667236","article-title":"Tumor heterogeneity: does it matter?","volume":"19","author":"Turnquist","year":"2019","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"9","key":"10.1016\/j.jpba.2026.117444_bib14","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3390\/diagnostics11091555","article-title":"Breast cancer heterogeneity","volume":"11","author":"Fumagalli","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.jpba.2026.117444_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2025.126069","article-title":"Pentachlorophenol exposure, plasma metabolomic markers, and gestational diabetes mellitus: association and potential mediation analyses","volume":"372","author":"Wen","year":"2025","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.jpba.2026.117444_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116263","article-title":"Untargeted metabolomics of blood plasma samples of patients with hepatocellular carcinoma","volume":"248","author":"B\u00f6hmov\u00e1","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117444_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2025.116912","article-title":"Untargeted LC-MS\/MS based metabolomics profiling of colorectal cancer cell lines reveals potential hypoxia-associated biomarkers","volume":"263","author":"Nimer","year":"2025","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117444_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jpba.2016.06.040","article-title":"Metabolomic profile for the early detection of coronary artery disease by using UPLC-QTOF\/MS","volume":"129","author":"Xu","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117444_bib19","doi-asserted-by":"crossref","first-page":"19763","DOI":"10.1038\/srep19763","article-title":"Phenotypic characterization analysis of human hepatocarcinoma by urine metabolomics approach","volume":"6","author":"Liang","year":"2016","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.jpba.2026.117444_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23333","article-title":"Identification of potential metabolite markers for colon cancer and rectal cancer using serum metabolomics","volume":"34","author":"Wu","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"issue":"1","key":"10.1016\/j.jpba.2026.117444_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11306-023-02066-y","article-title":"Machine learning for predicting diabetic metabolism in the Indian population using polar metabolomic and lipidomic features","volume":"20","author":"Jain","year":"2023","journal-title":"Metabolomics"},{"issue":"9","key":"10.1016\/j.jpba.2026.117444_bib22","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/art.41733","article-title":"Serum metabolomics identifies dysregulated pathways and potential metabolic biomarkers for hyperuricemia and gout","volume":"73","author":"Shen","year":"2021","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.jpba.2026.117444_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3461572","article-title":"Urinary metabolomics study of patients with gout using gas chromatography-mass spectrometry","volume":"2018","author":"Li","year":"2018","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.jpba.2026.117444_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13075-018-1600-5","article-title":"Metabolomics approach by 1H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout","volume":"20","author":"Zhang","year":"2018","journal-title":"Arthritis Res. Ther."},{"issue":"7","key":"10.1016\/j.jpba.2026.117444_bib25","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0026-0495(97)90126-8","article-title":"Is the plasma uridine level a marker of the overproduction of uric acid?","volume":"46","author":"Yamamoto","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.jpba.2026.117444_bib26","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1046\/j.1523-1755.2001.59780084.x","article-title":"H. Schl\u00fcter, Characterization of p-hydroxy-hippuric acid as an inhibitor of Ca2+-ATPase in end-stage renal failure","volume":"78","author":"Jankowski","year":"2001","journal-title":"Kidney Int. Suppl."},{"issue":"8308","key":"10.1016\/j.jpba.2026.117444_bib27","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0140-6736(82)92785-4","article-title":"Leukotriene B4, an inflammatory mediator in gout","volume":"2","author":"Rae","year":"1982","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jpba.2026.117444_bib28","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/adb.12580","article-title":"Increased plasma oleoylethanolamide and palmitoleoylethanolamide levels correlate with inflammatory changes in alcohol binge drinkers: the case of HMGB1 in women","volume":"23","author":"Ant\u00f3n","year":"2018","journal-title":"Addict. Biol."},{"issue":"5","key":"10.1016\/j.jpba.2026.117444_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11906-016-0646-5","article-title":"Role of phosphodiesterase 5 and cyclic GMP in hypertension","volume":"18","author":"Mergia","year":"2016","journal-title":"Curr. Hypertens. Rep."},{"issue":"5611","key":"10.1016\/j.jpba.2026.117444_bib30","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/267534a0","article-title":"Increased cyclic GMP levels associated with contraction in muscle fibres of the giant barnacle","volume":"267","author":"Beam","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.jpba.2026.117444_bib31","article-title":"Evaluating renal injury characteristics in different rat models of hyperuricemia and elucidating pathological molecular mechanisms via serum metabolomics","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.jpba.2026.117444_bib32","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/nu9040395","article-title":"Fructose intake, serum uric acid, and cardiometabolic disorders: a critical review","volume":"9","author":"Caliceti","year":"2017","journal-title":"Nutrients"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526001123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526001123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:07:52Z","timestamp":1777572472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708526001123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":32,"alternative-id":["S0731708526001123"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117444","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unraveling the heterogeneity of hyperuricemia using untargeted metabolomics and statistical modeling","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117444"}}